chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed her second dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed her second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed her second dose) had resolved.            No treatment information was provided.  No concomitant medication was provided.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown with no associated AEs.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rash on bilateral ankles; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (Itchy rash on bilateral ankles) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash on bilateral ankles). At the time of the report, RASH PRURITIC (Itchy rash on bilateral ankles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  Treatment medications was not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up report received and injection site location was updated
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Paraesthesia
Clinical narrative: Arm was heavy; Tingling on the arm, face and legs; Numbness on the Arm, Face, and Legs; This spontaneous case was reported by a nurse and describes the occurrence of LIMB DISCOMFORT (Arm was heavy), PARAESTHESIA (Tingling on the arm, face and legs) and HYPOAESTHESIA (Numbness on the Arm, Face, and Legs) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm was heavy), PARAESTHESIA (Tingling on the arm, face and legs) and HYPOAESTHESIA (Numbness on the Arm, Face, and Legs). At the time of the report, LIMB DISCOMFORT (Arm was heavy), PARAESTHESIA (Tingling on the arm, face and legs) and HYPOAESTHESIA (Numbness on the Arm, Face, and Legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information reported   Several patients, various age and sex, received the Moderna COVID-19 vaccine. They all complain of Tingling, and numbness on the Arm, Face, or Legs. Some patients report tingling right away, some within 15 minutes post vaccination and some patients report it a little later. Another patient's arm was heavy and tingling.   This case was linked to MOD-2021-180790.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: ADR: Reporter address, vaccine lot #s, administration date/sites, PMH,
Sex: U
Vaccine: COVID19
Symptoms: Product expiration date issue, Product physical issue
Clinical narrative: Vials were dropped; 3-6-2021 expiration on vial; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT PHYSICAL ISSUE (Vials were dropped) and PRODUCT EXPIRATION DATE ISSUE (3-6-2021 expiration on vial) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0028218) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 06-Mar-2021, the patient experienced PRODUCT PHYSICAL ISSUE (Vials were dropped) and PRODUCT EXPIRATION DATE ISSUE (3-6-2021 expiration on vial). At the time of the report, PRODUCT PHYSICAL ISSUE (Vials were dropped) and PRODUCT EXPIRATION DATE ISSUE (3-6-2021 expiration on vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Director of Nursing stated they held Covid Clinic on 2-6-2021 and administered 300 vaccines. Director stated that during preparation one of the vials were dropped and 75% frozen. Director stated that they returned vial to refrigerator. Director wants to know can they still use vial. Consent to email and call.
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Pyrexia
Clinical narrative: high fever; skin is aching; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events high fever, skin is aching.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: UNKNOWN) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events, high fever, skin is aching.  Treatment details included UNKNOWN.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of events, high fever, skin is aching was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Eye irritation, Heart rate, Heart rate abnormal, Swelling of eyelid
Clinical narrative: Eyes were burning; eyelids swollen; my heart rate went from resting to 116; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic shock (Due to penicillin allergy).    On 05-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, EYE IRRITATION (Eyes were burning), SWELLING OF EYELID (eyelids swollen) and HEART RATE ABNORMAL (my heart rate went from resting to 116) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: unknown (High) 116.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was given Benadryl and was observed for 30 minutes. List of concomitant medication were not given.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Product dose omission issue, Pruritus
Clinical narrative: declined to take the 2nd dose; Body itching; Right foot became swollen, red and hot; Right foot became swollen, red and hot; Right foot became swollen, red and hot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Body itching), PERIPHERAL SWELLING (Right foot became swollen, red and hot), ERYTHEMA (Right foot became swollen, red and hot), FEELING HOT (Right foot became swollen, red and hot) and PRODUCT DOSE OMISSION ISSUE (declined to take the 2nd dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Patient had allergies to everything in her blood and is highly sensitive).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRURITUS (Body itching). In March 2021, the patient experienced PERIPHERAL SWELLING (Right foot became swollen, red and hot), ERYTHEMA (Right foot became swollen, red and hot) and FEELING HOT (Right foot became swollen, red and hot). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (declined to take the 2nd dose). At the time of the report, PRURITUS (Body itching) had not resolved, PERIPHERAL SWELLING (Right foot became swollen, red and hot), ERYTHEMA (Right foot became swollen, red and hot) and FEELING HOT (Right foot became swollen, red and hot) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (declined to take the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient doctor gave her an antibiotic shot and other medication and the swelling got better. She also stated that she had allergies to everything in her blood and is highly sensitive, so she declined to take the 2nd dose.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up received on 22-Jul-2021 and included new patient medical history was added, new events (peripheral swelling, erythema, feeling hot and missed dose) were added, treatment information for the patient was added.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (arm was sore) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: ibuprofen (patient was on tablet ibuprofen is noted.).  On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 06-Mar-2021, the patient experienced AXILLARY PAIN (arm was sore). At the time of the report, AXILLARY PAIN (arm was sore) outcome was unknown. Not Provided   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-038042 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Nausea
Clinical narrative: Headache; nausea; tiredness; joint pain; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tiredness) and ARTHRALGIA (joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included TRAMADOL for Pain.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tiredness) and ARTHRALGIA (joint pain). At the time of the report, HEADACHE (Headache), NAUSEA (nausea), FATIGUE (tiredness) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: arm was sore; redness which circles all the way around her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE ERYTHEMA (redness which circles all the way around her arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE ERYTHEMA (redness which circles all the way around her arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE ERYTHEMA (redness which circles all the way around her arm) outcome was unknown.            No concomitant medications were reported.  No treatment related information was reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Injection site pain, Pulmonary pain
Clinical narrative: Lungs hurts/lungs hurts when takes deep breath; Back and front part were hurting; Left upper arm is a little bit tender; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Lungs hurts/lungs hurts when takes deep breath), BACK PAIN (Back and front part were hurting) and INJECTION SITE PAIN (Left upper arm is a little bit tender) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 08-Mar-2021, the patient experienced PULMONARY PAIN (Lungs hurts/lungs hurts when takes deep breath), BACK PAIN (Back and front part were hurting) and INJECTION SITE PAIN (Left upper arm is a little bit tender). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency.   At the time of the report, PULMONARY PAIN (Lungs hurts/lungs hurts when takes deep breath) and BACK PAIN (Back and front part were hurting) had not resolved and INJECTION SITE PAIN (Left upper arm is a little bit tender) outcome was unknown.      No concomitant medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain in extremity
Clinical narrative: Arm pain; Feel fluish; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     Concurrent medical conditions included Myasthenia gravis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Arm pain), INFLUENZA LIKE ILLNESS (Feel fluish) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. No treatment information reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain
Clinical narrative: swollen lymph nodes; pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and LYMPHADENOPATHY (swollen lymph nodes) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Chemotherapy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (pain). On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, PAIN (pain) and LYMPHADENOPATHY (swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: Salty taste in her mouth; Little sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Salty taste in her mouth) and VACCINATION SITE PAIN (Little sore at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL for Hypertension.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Salty taste in her mouth) and VACCINATION SITE PAIN (Little sore at injection site). At the time of the report, DYSGEUSIA (Salty taste in her mouth) and VACCINATION SITE PAIN (Little sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Extreme sleepiness) and FATIGUE (Some fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included BENAZEPRIL, HYDROCHLOROTHIAZIDE, AMLODIPINE and DIFLUPREDNATE (DUREZOL) for an unknown indication. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Extreme sleepiness) and FATIGUE (Some fatigue). At the time of the report, SOMNOLENCE (Extreme sleepiness) and FATIGUE (Some fatigue) outcome was unknown. Not Provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: Warm to touch skin around injection site; Hard around injection site; Red around injection site; Left arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm soreness), VACCINATION SITE WARMTH (Warm to touch skin around injection site), VACCINATION SITE INDURATION (Hard around injection site) and VACCINATION SITE ERYTHEMA (Red around injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Left arm soreness). On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch skin around injection site), VACCINATION SITE INDURATION (Hard around injection site) and VACCINATION SITE ERYTHEMA (Red around injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Left arm soreness), VACCINATION SITE WARMTH (Warm to touch skin around injection site), VACCINATION SITE INDURATION (Hard around injection site) and VACCINATION SITE ERYTHEMA (Red around injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Nausea, Pyrexia
Clinical narrative: Bone Pain when lying in bed; Joint Pain; Chills; Fever 101 F; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Bone Pain when lying in bed), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 101 F) and NAUSEA (Nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced BONE PAIN (Bone Pain when lying in bed), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 101 F) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, BONE PAIN (Bone Pain when lying in bed), ARTHRALGIA (Joint Pain), CHILLS (Chills), PYREXIA (Fever 101 F) and NAUSEA (Nausea) outcome was unknown.            Concomitant medication was not provided   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: declined follow up
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Streptococcal infection
Clinical narrative: Strep infection; Rash all over the body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of STREPTOCOCCAL INFECTION (Strep infection) and RASH (Rash all over the body) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced STREPTOCOCCAL INFECTION (Strep infection) and RASH (Rash all over the body). The patient was treated with TRIAMCINOLONE (topical) at a dose of 1 dosage form and METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) at a dose of 1 dosage form. At the time of the report, STREPTOCOCCAL INFECTION (Strep infection) outcome was unknown and RASH (Rash all over the body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications included Antibiotics.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Cough, Headache, Pyrexia
Clinical narrative: Loss of taste; Wheezing; Cough; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills) and HEADACHE (Headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Loss of taste; Wheezing; Cough; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills) and HEADACHE (Headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, AGEUSIA (Loss of taste), WHEEZING (Wheezing), COUGH (Cough), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Heart rate, Nasopharyngitis, Pain
Clinical narrative: Felt a strong heat from the waist down / felt that heat all over her body from her head; Very cold; Pain; Tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt a strong heat from the waist down / felt that heat all over her body from her head), NASOPHARYNGITIS (Very cold), PAIN (Pain) and FATIGUE (Tired) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FEELING HOT (Felt a strong heat from the waist down / felt that heat all over her body from her head), NASOPHARYNGITIS (Very cold), PAIN (Pain) and FATIGUE (Tired). At the time of the report, FEELING HOT (Felt a strong heat from the waist down / felt that heat all over her body from her head), NASOPHARYNGITIS (Very cold), PAIN (Pain) and FATIGUE (Tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Heart rate: low (Low) Very low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching from the rash), RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots), MYALGIA (Severe muscle aches and body aches), CHILLS (Chills) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for Reflux gastritis, LEVOTHYROXINE and ATORVASTATIN for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced MYALGIA (Severe muscle aches and body aches), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever 100.4°F) and FATIGUE (Very tired/ A little tired). On 08-Mar-2021, the patient experienced PRURITUS (Itching from the rash) and RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PRURITUS (Itching from the rash), RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots) and FATIGUE (Very tired/ A little tired) outcome was unknown and MYALGIA (Severe muscle aches and body aches), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever 100.4°F) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching from the rash), RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots), MYALGIA (Severe muscle aches and body aches), CHILLS (Chills) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for Reflux gastritis, LEVOTHYROXINE and ATORVASTATIN for an unknown indication. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced MYALGIA (Severe muscle aches and body aches), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever 100.4°F) and FATIGUE (Very tired/ A little tired). On 08-Mar-2021, the patient experienced PRURITUS (Itching from the rash) and RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PRURITUS (Itching from the rash), RASH (Rash on her neck, rash on her torso, little rash in her leg, little spots) and FATIGUE (Very tired/ A little tired) outcome was unknown and MYALGIA (Severe muscle aches and body aches), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever 100.4°F) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Illness, Pain in extremity, Pruritus
Clinical narrative: Itching; Felt not his best/terrible and sick described as having no energy and could hardly move; Headache suspected as migraine; Sore arm muscle; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), PAIN IN EXTREMITY (Sore arm muscle), ILLNESS (Felt not his best/terrible and sick described as having no energy and could hardly move) and HEADACHE (Headache suspected as migraine) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Penicillin allergy and Drug allergy (benadryl). Concomitant products included FINASTERIDE and TAMSULOSIN for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm muscle). On 27-Feb-2021, the patient experienced ILLNESS (Felt not his best/terrible and sick described as having no energy and could hardly move) and HEADACHE (Headache suspected as migraine). On 28-Feb-2021, the patient experienced PRURITUS (Itching). On 28-Feb-2021, HEADACHE (Headache suspected as migraine) had resolved. On 04-Mar-2021, ILLNESS (Felt not his best/terrible and sick described as having no energy and could hardly move) had resolved. On 05-Mar-2021, PRURITUS (Itching) and PAIN IN EXTREMITY (Sore arm muscle) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines included blood pressure medicine.  The patient frequently washed the itching areas and applied rubbing alcohol to the itching areas. Because he did not know which medicines to use to treat the reported symptoms, he did not take any medications to treat his symptoms
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Coronavirus infection, Dizziness, Malaise, Pain in extremity, SARS-CoV-2 test
Clinical narrative: felt light headed; arm was just sore initially; Wasn't feeling well; I have the Corona; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt light headed), PAIN IN EXTREMITY (arm was just sore initially), MALAISE (Wasn't feeling well) and CORONAVIRUS INFECTION (I have the Corona) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ZINC and AMLODIPINE for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (felt light headed), PAIN IN EXTREMITY (arm was just sore initially), MALAISE (Wasn't feeling well) and CORONAVIRUS INFECTION (I have the Corona). At the time of the report, DIZZINESS (felt light headed), PAIN IN EXTREMITY (arm was just sore initially), MALAISE (Wasn't feeling well) and CORONAVIRUS INFECTION (I have the Corona) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, SARS-CoV-2 test: negative (Negative) Negative. On 05-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.         Treatment details included Honey with tea.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: FollowUp Received on 01-JUL-2021: second dose details are added, events outcome was changed from unknown to Recovering/Resolving.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Achy arm; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achy arm) and ARTHRALGIA (Joint pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Achy arm) and ARTHRALGIA (Joint pain). At the time of the report, PAIN IN EXTREMITY (Achy arm) and ARTHRALGIA (Joint pain) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No Concomitant medications were provided. No Treatment information was reported.   This case was linked to MOD-2021-039133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: A follow up was received on 23-JUL-2021, The outcome of the event was updated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: hot to touch; Itchy; red rash; swollen; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (red rash) and VACCINATION SITE SWELLING (swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease, Anxiety and Arthritis. Concomitant products included ATENOLOL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), HYDROCHLOROTHIAZIDE (DIURETIC [HYDROCHLOROTHIAZIDE]), POTASSIUM and VITAMINS NOS for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FEELING HOT (hot to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (red rash) and VACCINATION SITE SWELLING (swollen). At the time of the report, FEELING HOT (hot to touch), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (red rash) and VACCINATION SITE SWELLING (swollen) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   The reporter denied to follow-up stating that she was doing fine.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2021: Follow-up received on 09-Mar-2021, event updated from unknown to recovering.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Feeling abnormal
Clinical narrative: Brain fog; Brain fog is so bad it effects her work; Joint pain; Muscle pain; Headache; Fever of 102F; Chills; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. o4(or9)0a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog), IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever of 102F), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, FEELING ABNORMAL (Brain fog) had not resolved, IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), MYALGIA (Muscle pain), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown and ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever of 102F) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.         Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 03-May-2021 contains non-significant information
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Myalgia, Nausea, Pyrexia
Clinical narrative: Brain fog; Brain fog is so bad it effects her work; Joint pain; Muscle pain; Headache; Fever of 102F; Chills; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. o4(or9)0a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Brain fog), IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain), HEADACHE (Headache), PYREXIA (Fever of 102F), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, FEELING ABNORMAL (Brain fog) had not resolved, IMPAIRED WORK ABILITY (Brain fog is so bad it effects her work), MYALGIA (Muscle pain), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown and ARTHRALGIA (Joint pain), HEADACHE (Headache), PYREXIA (Fever of 102F) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102F.         Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 03-May-2021 contains non-significant information
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Red knot at the site of injection; Itchy knot at the site of injection; Red knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). On an unknown date, the patient experienced VACCINATION SITE MASS (Red knot at the site of injection). At the time of the report, VACCINATION SITE MASS (Red knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Wrong technique in device usage process
Clinical narrative: Insufficient dose administered; RN was not familar with syringe; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INCORRECT DOSE ADMINISTERED (Insufficient dose administered) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (RN was not familar with syringe) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced INCORRECT DOSE ADMINISTERED (Insufficient dose administered) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (RN was not familar with syringe). On 05-Jan-2021, INCORRECT DOSE ADMINISTERED (Insufficient dose administered) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (RN was not familar with syringe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) (batch no. 41L20A) on her right arm.  Concomitant product use was not provided. Treatment information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Fever which went high up to 101.3.; She felt tired and worn out; Bodyaches; She felt crummy; Tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING ABNORMAL (She felt crummy), FATIGUE (Tired), MYALGIA (Bodyaches) and PYREXIA (Fever which went high up to 101.3.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired). On 28-Feb-2021, the patient experienced FEELING ABNORMAL (She felt crummy). On 01-Mar-2021, the patient experienced MYALGIA (Bodyaches). On 02-Mar-2021, the patient experienced PYREXIA (Fever which went high up to 101.3.) and FATIGUE (She felt tired and worn out). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Feb-2021, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired) had resolved. On 02-Mar-2021, FEELING ABNORMAL (She felt crummy), MYALGIA (Bodyaches), PYREXIA (Fever which went high up to 101.3.) and FATIGUE (She felt tired and worn out) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Pyrexia: 101.3 (High) recovered on 02mar2021.         Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Action item updated to Patient denied FU
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Pyrexia
Clinical narrative: Didn't feel well; Fever 100°F; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Didn't feel well) and PYREXIA (Fever 100°F) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Didn't feel well) and PYREXIA (Fever 100°F). On 28-Feb-2021, FEELING ABNORMAL (Didn't feel well) and PYREXIA (Fever 100°F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (High) 100 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included medications for blood pressure and cholesterol. Treatment information was not provided.